Meisner Derek M's Form 4 filing
Acumen Pharmaceuticals, Inc. (ABOS) · filed Jan 28, 2026
- Accession no.
- 0001628280-26-003948
- Filed
- Jan 28, 2026
- Trade date
- Jan 26-28, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $53.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meisner Derek MCIK 0001752461 | Officer (Chief Legal Officer & Corp Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Common Stock | MOption exerciseAcquired | +15,085 | $1.85 | +$27,907.25 | 189,084 | Direct | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −15,085 | $3.00 | −$45,255 | 173,999 | Direct | |
| Jan 28, 2026 | Common Stock | MOption exerciseAcquired | +2,671 | $1.85 | +$4,941.35 | 176,670 | Direct | |
| Jan 28, 2026 | Common Stock | SSaleDisposed | −2,671 | $3.00 | −$8,013 | 173,999 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Common Stock | MOption exerciseDisposed | −15,085 | $0.00 | $0 | 85,215 | Direct | |
| Jan 28, 2026 | Common Stock | MOption exerciseDisposed | −2,671 | $0.00 | $0 | 82,544 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.